Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Vulvar cancer staging

Introduction

Overview

Overview

According to the FIGO cancer staging system, there are 4 stages of vulvar cancer.[1]

Staging

Staging

According to the FIGO cancer staging system, there are 4 stages of vulvar cancer.[1][2][3][4][5][6][7]

Stage Findings
Stage I Tumor confined to the vulva
IA Lesions ≤2 cm in size, confined to the vulva or perineum and with stromal invasion ≤1.0 mmb, no nodal metastasis
IB Lesions >2 cm in size or with stromal invasion >1.0 mmb, confined to the vulva or perineum, with negative nodes
Stage II Tumor of any size with extension to adjacent perineal structures (lower third of urethra, lower third of vagina, anus) with negative nodes
Stage III Tumor of any size with or without extension to adjacent perineal structures (lower third of urethra, lower third of vagina, anus) with positive inguinofemoral lymph nodes.
IIIA (i) With 1 lymph node metastasis (≥5 mm), or
(ii) With 1–2 lymph node metastasis (<5 mm)
IIIB (i) With 1 lymph node metastasis (≥5 mm), or
(ii) With 1–2 lymph node metastasis (<5 mm)
IIIC With positive nodes with extracapsular spread
Stage IV Tumor invades other regional (upper 2/3 urethra, upper 2/3 vagina), or distant structures
IVA Tumor invades any of the following:
(i) Upper urethral and/or vaginal mucosa, bladder mucosa, rectal mucosa, or fixed to pelvic bone, or
(ii) Fixed or ulcerated inguinofemoral lymph nodes
IVB Any distant metastasis including pelvic lymph nodes
References

References

  1. ↑ 1.0 1.1 Stage Information for Vulvar Cancer. National Cancer Institute. http://www.cancer.gov/types/vulvar/hp/vulvar-treatment-pdq#section/_16 Accessed on September 25, 2015
  2. ↑ Pecorelli S (May 2009). “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium”. Int J Gynaecol Obstet. 105 (2): 103–4. PMID 19367689.
  3. ↑ Hacker NF, Barlow EL (August 2015). “Staging for vulvar cancer”. Best Pract Res Clin Obstet Gynaecol. 29 (6): 802–11. doi:10.1016/j.bpobgyn.2015.01.004. PMID 25842047.
  4. ↑ Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R (June 1993). “Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)”. Gynecol. Oncol. 49 (3): 279–83. doi:10.1006/gyno.1993.1127. PMID 8314530.
  5. ↑ Shanbour KA, Mannel RS, Morris PC, Yadack A, Walker JL (December 1992). “Comparison of clinical versus surgical staging systems in vulvar cancer”. Obstet Gynecol. 80 (6): 927–30. PMID 1448261.
  6. ↑ Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J (June 1995). “The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients”. Gynecol. Oncol. 57 (3): 327–34. doi:10.1006/gyno.1995.1151. PMID 7774836.
  7. ↑ Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, Soldà M, Coscio S, Spinetti G, Maneo A, Ferrero A, Konishi De Toffoli G (July 2000). “Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study”. Cancer. 89 (1): 116–22. PMID 10897008.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Syed Musadiq Ali M.B.B.S.[3]